Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.

CONCLUSION: To the best of our knowledge, this is the first report investigating the efficacy of the combination of CT and HT in the neoadjuvant treatment of hormone receptor positive BC. PMID: 29344722 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29344722?dopt=Abstract

Source: Clinical Genitourinary Cancer - January 17, 2018 Category: Cancer & Oncology Authors: Generali D, Corona SP, Pusztai L, Rouzier R, Allevi G, Aguggini S, Milani M, Strina C, Frati A Tags: J Cancer Res Clin Oncol Source Type: research